Melis, ValeriaMagbagbeolu, MandyRickard, Janet EHorsley, DavidDavidson, KathleenHarrington, Kathleen AGoatman, KeithGoatman, Elizabeth ADeiana, SerenaClose, Steve PZabke, ClaudiaStamer, KarstenDietze, SilkeSchwab, KarimaStorey, John M DHarrington, Charles RWischik, Claude MTheuring, FranzRiedel, Gernot2015-05-282015-05-282015-06Melis, V, Magbagbeolu, M, Rickard, J E, Horsley, D, Davidson, K, Harrington, K A, Goatman, K, Goatman, E A, Deiana, S, Close, S P, Zabke, C, Stamer, K, Dietze, S, Schwab, K, Storey, J M D, Harrington, C R, Wischik, C M, Theuring, F & Riedel, G 2015, 'Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models', Behavioural Pharmacology, vol. 26, no. 4, pp. 353-368. https://doi.org/10.1097/FBP.00000000000001330955-8810ORCID: /0000-0002-5261-5467/work/73579126ORCID: /0000-0001-7063-7136/work/96652490ORCID: /0000-0003-2250-3920/work/47672899http://hdl.handle.net/2164/4568Acknowledgements The authors acknowledge the contributions of Bettina Seelhorst (histological analysis), Anna Thoma (animal care), Marlene Arthur (animal dosing) and Pierre-Henri Moreau (experimental discussions). This work was supported by TauRx Therapeutics Ltd., Singapore.161029653enganimal modelslearning and memoryleucomethylithioniniummethylene blueratRotaRodtaupathieswater mazeRM Therapeutics. PharmacologyRMJournal article10.1097/FBP.0000000000000133264